<table id="table2" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2. The Influence of Age, Liver and Kidney Function, on the Clearance and Terminal Half-life of Ketorolac Tromethamine (IM<footnote id="table2a">Estimated from 30 mg single IM doses of ketorolac tromethamine</footnote> and ORAL<footnote id="table2b">Estimated from 10 mg single oral doses of ketorolac tromethamine</footnote>) In Adult Population</caption>
<col align="center" valign="middle" width="40%"></col>
<col align="center" valign="middle" width="15%"></col>
<col align="center" valign="middle" width="15%"></col>
<col align="center" valign="middle" width="15%"></col>
<col align="center" valign="middle" width="15%"></col>
<thead>
<tr stylecode="Botrule">
<th stylecode="Lrule Rrule"></th>
<th colspan="2" stylecode="Rrule">Total Clearance [in L/h/kg]<footnote id="table2c">Liters/hours/kilogram</footnote>
</th>
<th colspan="2" stylecode="Rrule">Terminal Half-life [in hours]</th>
</tr>
<tr>
<th stylecode="Lrule Rrule">Type of Subjects</th>
<th stylecode="Rrule">IM<br/>Mean (range)</th>
<th stylecode="Rrule">ORAL<br/>Mean (range)</th>
<th stylecode="Rrule">IM<br/>Mean (range)</th>
<th stylecode="Rrule">ORAL<br/>Mean (range)</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Normal Subjects IM (n=54)<br/>mean age=32, range=18–60<br/>Oral (n=77)<br/>mean age=32, range=20–60</td>
<td stylecode="Rrule">0.023<br/>(0.010–0.046)</td>
<td stylecode="Rrule">0.025<br/>(0.013–0.050)</td>
<td stylecode="Rrule">5.3<br/>(3.5–9.2)</td>
<td stylecode="Rrule">5.3<br/>(2.4–9.0)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Healthy Elderly Subjects<br/>IM (n=13), Oral (n=12)<br/>mean age=72, range=65–78</td>
<td stylecode="Rrule">0.019<br/>(0.013–0.034)</td>
<td stylecode="Rrule">0.024<br/>(0.018–0.034)</td>
<td stylecode="Rrule">7.0<br/>(4.7–8.6</td>
<td stylecode="Rrule">6.1<br/>(4.3–7.6)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Patients with Hepatic Dysfunction<br/>IM and Oral (n=7)<br/>mean age=51, range=43–64</td>
<td stylecode="Rrule">0.029<br/>(0.013–0.066)</td>
<td stylecode="Rrule">0.033<br/>(0.019–0.051)</td>
<td stylecode="Rrule">5.4<br/>(2.2–6.9)</td>
<td stylecode="Rrule">4.5<br/>(1.6–7.6)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Patients with Renal Impairment<br/>IM (n=25), Oral (n=9)<br/>serum creatinine=1.9–5.0 mg/dL<br/>mean age (IM)=54, range 35–71<br/>mean age (Oral)=57, range=39–70</td>
<td stylecode="Rrule">0.015<br/>(0.005–0.043)</td>
<td stylecode="Rrule">0.016<br/>(0.007–0.052)</td>
<td stylecode="Rrule">10.3<br/>(5.9–19.2)</td>
<td stylecode="Rrule">10.8<br/>(3.4–18.9)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Renal Dialysis Patients<br/>IM and Oral (n=9)<br/>mean age=40, range=27–63</td>
<td stylecode="Rrule">0.016<br/>(0.003–0.036)</td>
<td stylecode="Rrule">---</td>
<td stylecode="Rrule">13.6<br/>(8.0–39.1)</td>
<td stylecode="Rrule">---</td>
</tr>
</tbody>
</table>